Drupal.behaviors.print = function(context) {window.print();window.close();}>

Illumina Q2 Revenues Down 2 Percent

July 25, 2012

Illumina Q2 Revenues Down 2 Percent

By a GenomeWeb staff reporter

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories

Illumina Sends Third Letter Asking Shareholders to Reject Roche Bid, Roche Disappointed by Illumina's Continued Rebuff

April 3, 2012 / GenomeWeb Daily News
NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD

April 24, 2013 / Clinical Sequencing News
Resurgence in HiSeq Sales Helps Drive Illumina Revenue Growth in Q1 2013

April 23, 2013 / In Sequence
MiSeq, Consumables, Services Drive Illumina's Q4 Revenues as it Begins Work on Nanopore Sequencing

January 29, 2013 / In Sequence
Analysts Increase Valuations, Upgrade Illumina

January 4, 2013 / GenomeWeb Daily News